On the 18th, President Moon Jae-in visited Poonglim Pharmatech, the production site for the least residual type (LDS) vaccine for corona 19 vaccination in Gunsan, Jeollabuk-do, and listened to the explanation of the vaccine syringe production line from Poonglim Pharmatech vice president Mihee Cho. Gunsan = Senior Reporter Wang Tae-seok
On the 18th, President Moon Jae-in visited a company that develops a vaccine syringe for the least residual type (LDS) novel coronavirus infection (Corona 19) and said, “We will surely lead to success in vaccination starting on the 26th.” A typical syringe can inoculate 5 people with one bottle of vaccine, but an LDS syringe can inoculate up to 6 people with a minimal amount of vaccine.
President Moon visited Poonglim Pharmatech in Gunsan, Jeollabuk-do on that day and stressed that “the government has secured sufficient quantities of vaccines and syringes, and prepared a vaccination plan thoroughly.” Officials from Shin-A Yanghaeng and Doowon Meditech, who make LDS syringes, also attended this day.
President Moon praised the LDS syringe, saying, “The world’s attention is focused, and global pharmaceutical companies and medically advanced countries are taking their lives and deaths to secure them.” “After the diagnostic kit, we have shown the excellence of K quarantine again.” did. “We are very happy to inform the public about the excellence of our products.”
In the case of Poonglim Pharmatech, with the help of Samsung Electronics and the government, it completed the process from prototype production to production in one month. It was also approved by the US Food and Drug Administration (FDA) on the 17th with the help of Samsung Biofes and the Food and Drug Administration. Currently, it is said that more than 260 million supply requests are inundated from over 20 countries around the world, including the United States and Japan, including Pfizer. President Moon picked up Samsung and said, “We cooperated in all directions. Thank you.”
President Moon said, “Punglim Pharmatech will provide 127,000 syringes free of charge to the public. The government plans to purchase 40 million syringes from Shin-Ayang and Doowon Meditech and use them for vaccination.” He emphasized, “Going forward, the government will actively support the innovation of Korean SMEs by supporting smart factories, designating new free regulatory zones, and establishing an innovation procurement system.”
Stop reporter [email protected]
News directly edited by the Hankook Ilbo can also be viewed on Naver.
